naringenin has been researched along with Burkitt Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH; Lee, JK | 1 |
1 other study(ies) available for naringenin and Burkitt Lymphoma
| Article | Year |
|---|---|
Naringenin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt's lymphoma cells.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Line, Tumor; Flavanones; Humans; Killer Cells, Natural; NK Cell Lectin-Like Receptor Subfamily K | 2015 |